These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37147841)

  • 1. [Introduction for
    Gao WJ; Liao CX; Li LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Apr; 44(4):657-661. PubMed ID: 37147841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoonoses: beyond the human-animal-environment interface.
    The Lancet
    Lancet; 2020 Jul; 396(10243):1. PubMed ID: 32622381
    [No Abstract]   [Full Text] [Related]  

  • 3. Expanding beyond zoonoses: the benefits of a national One Health coordination mechanism to address antimicrobial resistance and other shared health threats at the human-animal-environment interface in Kenya.
    Kimani T; Kiambi S; Eckford S; Njuguna J; Makonnen Y; Rugalema G; Morzaria SP; Lubroth J; Fasina FO
    Rev Sci Tech; 2019 May; 38(1):155-171. PubMed ID: 31564733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The One Health Concept.
    Pitt SJ; Gunn A
    Br J Biomed Sci; 2024; 81():12366. PubMed ID: 38434675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The United Nations and One Health: the International Health Regulations (2005) and global health security.
    Nuttall I; Miyagishima K; Roth C; de La Rocque S
    Rev Sci Tech; 2014 Aug; 33(2):659-68. PubMed ID: 25707192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern agriculture and One Health.
    Zhang G; Qiu Y; Boireau P; Zhang Y; Ma X; Jiang H; Xin T; Zhang M; Tadesse Z; Wani NA; Song J; Ding J
    Infect Dis Poverty; 2024 Oct; 13(1):74. PubMed ID: 39385259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operationalization of One Health and tripartite collaboration in the Asia-Pacific region.
    Gongal G; Ofrin RH; de Balogh K; Oh Y; Kugita H; Dukpa K
    WHO South East Asia J Public Health; 2020 Apr; 9(1):21-25. PubMed ID: 32341217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Four-Way Linking to a One Health Platform in Egypt: institutionalisation of a multidisciplinary and multisectoral One Health system.
    Allal L; Mahrous H; Saad A; Refaei S; Attia M; Mahrous I; Fahim M; Elfadaly S; Abdelnabi A
    Rev Sci Tech; 2019 May; 38(1):261-270. PubMed ID: 31564724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergising tools for capacity assessment and One Health operationalisation.
    Pelican K; Salyer SJ; Barton Behravesh C; Belot G; Carron M; Caya F; De La Rocque S; Errecaborde KM; Lamielle G; Latronico F; Macy KW; Mouille B; Mumford E; Shadomy S; Sinclair JR; Dutcher T
    Rev Sci Tech; 2019 May; 38(1):71-89. PubMed ID: 31564739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One Health in Mongolia.
    Batsukh Z; Tsolmon B; Otgonbaatar D; Undraa B; Dolgorkhand A; Ariuntuya O
    Curr Top Microbiol Immunol; 2013; 366():123-37. PubMed ID: 23065105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAO and the One Health approach.
    Lubroth J
    Curr Top Microbiol Immunol; 2013; 366():65-72. PubMed ID: 22949033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Promoting implementation research and One Health approach to respond the four global health challenges: an interpretation of the Special Programme for Research and Training in Tropical Diseases (TDR) Strategy 2024-2029].
    Fang J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Apr; 36(1):13-16. PubMed ID: 38604680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One health systems strengthening in countries: Tripartite tools and approaches at the human-animal-environment interface.
    de la Rocque S; Errecaborde KMM; Belot G; Brand T; Shadomy S; von Dobschuetz S; Aguanno R; Carron M; Caya F; Ding S; Dhingra M; Donachie D; Gongal G; Hoejskov P; Ismayilova G; Lamielle G; Mahrous H; Marrana M; Nzietchueng S; Oh Y; Pinto J; Roche X; Riviere-Cinnamond A; Rojo C; Scheuermann L; Sinclair J; Song J; Skrypnyk A; Traore T; Wongsathapornchai K
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36707093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concept of one health applied to the problem of zoonotic diseases.
    Shaheen MNF
    Rev Med Virol; 2022 Jul; 32(4):e2326. PubMed ID: 35060214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing global insight into AMR spread and generation: prospects and limitations of the WHO and quadripartite research agendas.
    Fieldman T; Mossialos E; Anderson M
    J Antimicrob Chemother; 2024 Feb; 79(2):207-210. PubMed ID: 38153237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings.
    Lavan RP; King AI; Sutton DJ; Tunceli K
    Vaccine; 2017 Mar; 35(13):1668-1674. PubMed ID: 28216188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Global and national strategies against antibiotic resistance].
    Abu Sin M; Nahrgang S; Ziegelmann A; Clarici A; Matz S; Tenhagen BA; Eckmanns T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 May; 61(5):507-514. PubMed ID: 29589040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing One human-animal-environment Health for global health security: what does the evidence say?
    Zinsstag J; Kaiser-Grolimund A; Heitz-Tokpa K; Sreedharan R; Lubroth J; Caya F; Stone M; Brown H; Bonfoh B; Dobell E; Morgan D; Homaira N; Kock R; Hattendorf J; Crump L; Mauti S; Del Rio Vilas V; Saikat S; Zumla A; Heymann D; Dar O; de la Rocque S
    Lancet; 2023 Feb; 401(10376):591-604. PubMed ID: 36682371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An approach for embedding behavioural science in antimicrobial resistance One Health research.
    Chadborn T; Williams S; Jorgensen T; Price C; Buckel A; Altieri E
    J Infect Public Health; 2023 Dec; 16 Suppl 1():134-140. PubMed ID: 37973498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Opportunities in the Use of High and Maximum Biocontainment Facilities in Developing and Licensing Risk Group 3 and Risk Group 4 Agent Veterinary Vaccines.
    Brake DA; Kuhn JH; Marsh GA; Beer M; Fine JB
    ILAR J; 2022 Jan; 61(1):46-61. PubMed ID: 33712856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.